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Abstract Some aspects of the roles of inositol trisphosphate 
(Insp3) and inositol tetrakisphosphate (Insp4) in Ca2+ home-
ostasis in terms of inositol trisphosphate 3-kinase B (IP3K-B) 
localization and activity are discussed. The model that we 
propose is also compatible with IP3K-B participating in the 
widely reported phenomenon of quantal release of Ca + from 
internal stores, at least in some biological systems. 
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1. Introduction 
Inositol 1,4,5-trisphosphate (Insp3) is a second messenger 
that mediates the release of Ca2+ from intracellular stores. 
Binding of ligands to specific plasma membrane receptors 
triggers the hydrolysis of membrane-associated phosphatidyl 
inositol bisphosphate (PIP2) by phospholipase C (PLC) into 
soluble Insp3 and membrane-bound diacylglycerol [1]. 
Although the role of Insp3 in Ca2+ homeostasis is well 
understood, much less is known about the role of its metab-
olites. Of particular interest is the product of inositol 1,4,5-
trisphosphate 3-kinase (IP3K), inositol 1,3,4,5-tetrakisphos-
phate (Insp4), which has been postulated to regulate Ca2+ 
influx through the plasma membrane [2]. The recent purifica-
tion and cloning of an Insp4-binding protein with both ras-
and rap-GAP activity (GAP1IP4BP) [3] may support a role for 
Insp4 in extracellular Ca2+ influx. In short, Insp4 binds and 
activates GAP1 IP4BP in platelets, the final effect probably 
being inactivation of a small G protein, possibly raplB [4,5]. 
Since binding of Insp4 to GAP1 IP4BP would finally inactivate 
the G protein, it can follow that Insp4 may regulate Ca2+ 
influx from the plasma membrane in a GTP-dependent man-
ner, at least in platelets. Thus, Insp4 is of clear physiological 
importance and potentially links the Insp3 signal transduction 
pathway with GTP-regulated signalling mechanisms. 
2. Experimental 
2.1. Cell culture and immunofluorescence microscopy 
Normal rat kidney (NRK) cells were grown in RPMI-1640 
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medium (GIBCO, Life Technologies, Ltd., Paisley, Scotland), 
2 mM glutamine (GIBCO), 100 |i.g/ml streptomycin (Evans 
Medical, Ltd., Langhurst, Horsham, UK) and 60 ^g/ml pen-
icillin (Glaxo Laboratories, Ltd., Greenford, UK) at 37°C in 
5% CO2. Immunofluorescence was performed as previously 
described [31], using polyclonal antibody 52 (against the N-
terminal 12 amino acids of rat IP3K-B) and a polyclonal anti-
body versus Insp3 receptor type I (a kind gift from Dr. J.-P. 
Mauger, Institute Pasteur, Paris) [32]. 
3. Inositol 1,4,5-trisphosphate 3-kinase activities 
As mentioned above, the conversion of Insp3 into Insp4 is 
catalysed by inositol 1,4,5-trisphosphate 3-kinases (IP3Ks) [6]. 
This activity has been shown to be associated with a variety of 
low molecular weight, mainly cytosolic, proteins [7-12] which 
are activated by Ca2+ and calmodulin [8,12-16]. Do these 
proteins represent multiple isoforms of IP3Ks, or are they 
proteolytic fragments of a more limited number of IP3K iso-
forms? The sequences of A and B isoforms of rat and human 
IP3K have been published [17-19], so different isoforms of the 
enzyme do exist. However, cloning of the B isoform of rat 
IP3K (IP3K-B) [20] showed that the initiating Met is in fact 
205 amino acids upstream of that initially reported for the 
human orthologue of this enzyme [19] and that whilst the A 
and B isoforms share a catalytic region (the C-terminus of the 
B isoform and the entirety of the A isoform), the N-terminal 
320 amino acids are unique to the B isoform [19]. In addition, 
the full-length IP3K-B is not only cytosolic. It has also been 
shown to bind to the cytosolic face of a well-defined area of 
the ER membrane system, via high-affinity, conformation-de-
pendent, protein-protein interactions, and to have an appar-
ent molecular weight of 90 kDa (Soriano et al., submitted). 
Moreover, we show here that the membrane localization of 
IP3K-B overlaps with that of Insp3 receptor type I, as seen by 
immunofluorescence (Fig. 1), implying that the membranes 
involved are those of the internal Ca2+ stores. 
Thus, whilst some of the reported IP3K activity associated 
with low molecular weight, cytosolic proteins may correspond 
to different isoforms of IP3K, some are likely to derive from 
proteolytic release of C-terminal, catalytically active frag-
ments from IP3K-B (and other isoforms). This hypothesis is 
supported by the observation that IP3K is highly sensitive to 
proteases, in particular calpain, and it is common to find 
several degradation products of IP3K even in fresh prepara-
tions [10,18]. 
Here we discuss some aspects of Insp3 and Insp4 roles in 
Ca2+ homeostasis in terms of IP3K-B localization and activ-
ity. 
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NRK cells. Cells were processed for immunofluorescence as described in Fig. 1. Colocalization of Insp3 receptor type I (A) and IP3K-B (B) in 
Section 2. Bar: 10 |im. 
4. Possible roles of inositol 1,4,5-trisphosphate 3-kinase B in 
Ca2+ homeostasis 
There is extensive evidence showing that, at least in several 
biological systems, Insp3 and Insp4 may regulate Ca2+ mobil-
ization synergistically [33-35]. And more recently, evidence 
from Dawson's laboratory [36] strongly suggests that the syn-
ergistic effect of Insp4 is unlikely to be due to artefacts such as 
conversion into Insp3 or by contamination of Insp4 prepara-
tions with Insp3 traces. Moreover, it has also been shown that 
there is a mechanism requiring GTP which links Insp3-sensi-
tive and insensitive pools [25,27-29], and Irvine [37] has sug-
gested that Insp4 could regulate such GTP-dependent linking. 
Based on the fact that IP3K-B is membrane associated and 
localised to specific regions of the ER membrane system in-
volved in Ca2+ homeostasis (Fig. 1) (Soriano et al., submit-
ted), we take these ideas further and postulate that the mech-
anism for Ca2+ influx from the plasma membrane, dependent 
on small G proteins, and activated by Insp4, also exists in 
intracellular membranes; such a system would be analogous 
to different Rab proteins functioning in membrane traffic 
events involving different intracellular membranes. In our 
model, based on the localization and activity of IP3K-B, 
Insp3 would release Ca2+ from the ER during cell activation, 
which in turn would stimulate Insp4 production and subse-
quent Insp4-regulated Ca2+ release in a GTP-dependent man-
ner, in a similar way to that proposed for a Rap-like protein 
and Insp4 at the plasma membrane of platelets [4,5]. Thus, 
production of Insp4 on ER membranes would cause Ca2+ 
release into the cytosol, as it causes Ca2+ influx from the 
plasma membrane. 
Although Insp3 receptors may be regulated in several ways, 
including covalent modifications [21], the partial co-localiza-
tion with IP3K-B, the enzyme distribution being more re-
stricted, offers an additional regulatory mechanism, since 
only the receptors proximal to the enzyme would be further 
activated by the G protein-dependent pathway. 
It might be argued that, because of its rapid rate of difu-
sion, there would be no need for the in situ generation of 
Insp4. However, the key step in the above scheme is not so 
much the downstream effects of Insp4 production but rather 
regulation of that production, i.e. the activation of IP3K-B, 
an enzyme which is activated by Ca2+. Proximity of IP3K-B 
to the Ca2+ channel of the Insp3 receptor provides the ideal 
microenvironment for such modulation of enzyme activity. 
5. Quantal release from intracellular Ca2+ stores 
The preceding model also provides one explanation for the 
widely reported phenomenon of quantal release of Ca2+ from 
internal stores, at least in some biological systems. 
It has been proposed that there are both Insp3-sensitive and 
Insp3-insensitive Ca2+ stores in the ER, and this idea has been 
used to explain the phenomenon of quantal release, by which 
the release of Ca2+ from intracellular stores can be graded 
[22,23]. However, it has also been argued that, in a large 
number of cases, experimental procedures for cell permeabili-
zation can account for the apparent quantal release [26]. It 
has been reported that, in intact cells, all Ca2+ stores are 
available for Insp3 mobilization, whereas disruption of the 
cytoskeleton and/or inhibition of GTP-dependent interactions 
results in fragmentation into Insp3-sensitive and insensitive 
Ca2+ stores [24,25]. Treatments disrupting the cytoskeleton 
result in ER vesicularization [26], effectively causing luminal 
discontinuity, whereas inhibition of GTP-dependent interac-
tions disrupts membrane trafficking by interfering with both 
Rab and ARF G proteins. Also, and more relevantly, such 
inhibition would be predicted to inhibit Ca2+ influx from the 
plasma membrane by interfering with the action of G proteins 
[3-5]. We suggest that IP3K-B would participate in the 'bridg-
ing' of IP3-sensitive and insensitive Ca2+ stores in the systems 
where quantal Ca2+ release is observed. In the model that we 
suggest, outlined in Fig. 2, Ca2+ stores would be continuous 
in normal conditions, and Insp3 and Insp4 would work in 
conjunction to release Ca2+, the latter by activating a pathway 
analogous to the one present for Insp4 and a G protein on the 
plasma membranes of human platelets (Fig. 2A). In this case, 
graded release of Ca2+ would be achieved by graded activa-
tion of IP3K-B, according to the initial, Insp3-induced, Ca2+ 
release, which would in turn activate a subset of the IP3K-B 
population. In short, IP3K-B would be responsible for the 
Ca2+-induced Ca2+ release, by producing Insp4 and thereby 
S. Soriano, G. Banting IFEBS Letters 403 (1997) 1-4 
| P 3 w | P 4 ► rapGAP-like 
IP3K^ 
/ T - l ENDOI 
( RETICI 
IP3R 
/ U ENDOPLASMIC 
( I ULUM 
Full Ca2+ release 
IP3R 
Partial calcium release because the 
IP4-responsive mechanism is 
lacking.GTP would be unable to restore 
Ca2+ release from these vesicles 
rapGAP-like 
IP3R 
Partial Ca2+ release because IP4 is not 
produced. However, excess GTP would 
cause full Ca2+ release, possibly by 
acting on a translocated G protein on the 
vesicle, downstream of activation by IP4 
Fig. 2. Possible role of IP3K-B in calcium homeostasis in intact (A) 
or disrupted (B,C) Ca2+ stores. See text for full explanation. 
activating the GTP-dependent further Ca2+ release. Therefore, 
quantal Ca2+ release, at least in some systems, would be de-
pendent on the relative amounts, and degree of association, of 
IP3K-B and Insp3 receptor. The more IP3K-B present in 
proximity to Insp3 receptors, the more likely it is that all 
Ca2+ is released by a single dose of Insp3, since more IP3K-
B would be activated by the release of Ca2+ via Insp3 recep-
tors, leading to further release of Ca2+ (potentially from 
Insp3-insensitive stores) in an Insp4-regulated, GTP-depend-
ent manner. 
Different types of vesiculated structures ('vesicles') are 
formed under conditions which fragment the ER. These 
would be predicted to contain various combinations of 
IP3K-B, Insp3 receptor and the Insp4-regulated, G protein-
containing system for the release of intracellular Ca2+ stores. 
The large majority of these 'vesicles' will contain the Insp3 
receptor, but fewer will also contain IP3K-B and the appro-
priate G protein. Those containing all components (Fig. 2B) 
will release all Ca2+. The ones containing both Insp3 receptor 
and IP3K-B, but lacking the G protein components will re-
lease Ca2+ only partially after IP3 activation (Fig. 2C). GTP 
would be unable to fully release Ca2+ from these 'vesicles'. 
Similarly, 'vesicles' lacking IP3K-B but containing the G com-
ponents will release Ca2+ only partially after Insp3 activation, 
but full release would be achieved after GTP addition, bypass-
ing the need for Insp4 production. This model would predict 
that, after GTP addition to permeabilised cells, there would 
be an apparent enlargement of the Insp3-sensitive intracellular 
Ca2+ store, although not to a full extent. Such an effect has 
been observed in permeabilised hepatocytes [25]. Also, the 
enhancing effect of GTP in Ca2+ release is well documented 
in liver microsomes and permeabilised hepatocytes [27-29]. 
The mechanism by which GTP acts could be by helping in 
the fusion of different types of vesicles to increase luminal 
Ca2+ available for further release or by acting on individual 
vesicles. 
An absolute requirement for this model is that IP3K-B be 
either active or at least regulatable when associated to the ER 
membrane. As mentioned above, the enzyme has been shown 
to be both cytosolic and membrane-bound. Our results (S.S. 
and G.B. unpublished) indicate that both populations can 
produce Insp4. If this is the case, it is then possible that the 
presence of the N-terminus of the enzyme is only required to 
bind to the ER in the proximity of the IP3 receptor (it is 
intriguing to speculate that the Insp3 receptor itself could be 
the IP3K-B binding protein) so that it can be activated by the 
local Ca2+ concentrations, rather than by conformational 
changes brought about by shuttling from membrane to cyto-
sol or vice versa. 
As mentioned above, Insp3 receptors can be regulated in a 
variety of ways [21]. Which mechanism is chosen for receptor 
regulation is likely to depend on the system of study. Regu-
lation by IP3K-B could be present in tissues like liver, where 
the full-length enzyme was first cloned [20], or in kidney, 
where the restricted localization of the enzyme was first de-
scribed (Fig. 1) (Soriano et al., submitted). However, other 
cells may not express the B isoform of the enzyme (where 
Insp4 could be involved in Insp3 signal termination, or in 
Ca2+ influx). An example of this may be the finding in rat 
cerebellum that reconstituted vesicles containing purified 
Insp3 receptors release Ca2+ in a quantal fashion, suggesting 
that it is an inherent property of the receptors in this tissue 
[30]. Although this may well be the case, it is also true that the 
fact that purified Insp3 receptors show heterogeneity in their 
sensitivity to Insp3 does not provide information about the 
mechanism involved. For example, such heterogeneity may 
arise in the cerebellum by any known mechanism [21] and 
be carried along in the reconstitution of the vesicles. 
6. Conclusions 
In summary, some aspects of the regulation of IP3K-B have 
been addressed. Its localization to the cytosolic face of some 
ER membranes is likely to be relevant to its physiology, 
although its exact role in Ca2+ homeostasis remains unclear. 
We have outlined a model which is compatible with the data 
available from several biological systems. However, Ca2+ mo-
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bilization in other systems may remain unaffected by Insp4, or 
its role could be different from that proposed here, for exam-
ple removal of Insp3 or participation in C a 2 + influx. The 
latter would be particularly relevant to platelets, where a 
role for IP3K-B is difficult to imagine, since platelets do not 
have a well-defined intracellular membrane system (i.e. they 
contain a few granules but there is no indication of a 'proper ' 
endoplasmic reticulum). In summary, it is clear that the effect 
of Insp4 on C a 2 + mobilization varies considerably among cell 
lines, suggesting that the role of IP3K isoforms will depend on 
the system of study. 
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